What Does A Pet Scan Measure In The Body?

A PET scan measures how actively cells in your body are using glucose. That is the core of it. The scan does not show anatomy the way an X-ray or CT does — it shows metabolic activity, which is why it can reveal things that structural imaging misses. The full name is positron emission tomography, and the “measurement” it produces is a map of where certain cells are burning energy faster or slower than expected.

What Does A PET Scan Actually Measure?

PET measures the uptake of a radiotracer — a small amount of radioactive material attached to a molecule your body already uses. The most common tracer in oncology and many other applications is fluorodeoxyglucose, or FDG. It is a form of glucose with a radioactive label.

Cells that are consuming a lot of glucose pull in more FDG. The scanner detects the radiation the tracer emits and builds a three-dimensional image showing where that uptake is concentrated. High uptake appears as a “hot spot.” Low uptake appears cold.

The measurement itself is not a diagnosis. It is a signal. A hot spot means cells in that area are metabolically active. That could be cancer. It could also be infection, inflammation, or normal tissue that naturally uses a lot of glucose — the brain, for example, always lights up brightly on FDG-PET because it runs on glucose.

Different tracers measure different things. FDG measures glucose metabolism. Other tracers can measure blood flow, oxygen use, bone turnover, or the density of specific receptors. The tracer determines what the scan is actually measuring.

What Conditions Can a PET Scan Help Evaluate?

PET is used most often in cancer care. It can help stage tumors, check whether a treatment is working, and look for recurrence after treatment. Because it shows metabolic activity rather than just size, it can sometimes distinguish scar tissue from active tumor — something a CT scan alone cannot always do.

In cardiology, PET can assess blood flow to the heart muscle and whether heart tissue is still viable after a heart attack. In neurology, it is used in some cases to help evaluate certain types of dementia and seizure disorders, though its role varies by condition and is not universal.

PET is also used to evaluate some infections and inflammatory conditions. Because active immune cells also consume glucose, areas of significant inflammation can appear on the scan — which is both useful and a source of false positives.

It is worth being clear about what PET is not. It is not a routine screening test for healthy people. No major clinical guideline recommends whole-body PET screening in asymptomatic adults, and doing so carries real risks of false positives that lead to unnecessary procedures.

How Does a PET Scan Differ From a CT or MRI?

CT and MRI show structure. They show the shape, size, and location of organs and tissues. PET shows function — how metabolically active those tissues are.

This is why PET is often combined with CT or MRI in a single machine. The CT or MRI provides the anatomical map. The PET provides the activity data overlaid on top of it. A combined PET-CT lets a radiologist see that a hot spot is located in a specific lymph node, for example, rather than just knowing a hot spot exists somewhere in the chest.

Each modality has limits. CT and MRI can miss small deposits of cancer that have not yet changed the structure of tissue. PET can detect metabolic changes before structural changes appear, but it has lower spatial resolution — it cannot show fine detail the way CT can. That is why they are used together rather than as substitutes.

What Does Standardized Uptake Value (SUV) Mean?

The SUV is a number that quantifies how much tracer a tissue has taken up. It is calculated by comparing the concentration of tracer in a region of interest to the average concentration in the whole body.

Higher SUV generally means more metabolic activity. But there is no universal cutoff that separates cancer from non-cancer. Different tissues have different normal uptake. Different scanners and protocols produce different values. What counts as suspicious depends on the organ, the clinical context, and the judgment of the reading physician.

Some clinicians use an SUV threshold to help guide decisions, but the specific number varies by cancer type and institution. A single SUV value in isolation rarely tells the whole story. It is one piece of data among many — imaging appearance, location, patient history, and sometimes biopsy results.

What Can Cause a False Positive or False Negative?

False positives are common enough that they are a known limitation of PET. Anything that increases glucose metabolism in a tissue can create a hot spot. That includes:

• Infection or active inflammation
• Recent surgery or biopsy
• Radiation therapy (which can cause inflammation for weeks or months afterward)
• Brown fat, which burns glucose to generate heat and can light up in the neck and shoulders
• Normal organs with high glucose use, such as the brain, heart, and kidneys
• Certain benign tumors

False negatives also happen. Some cancers are not very glucose-avid — meaning they do not take up much FDG. Certain types of lung cancer, prostate cancer, and some lymphomas can be difficult to detect with FDG-PET for this reason. Small tumors below the resolution of the scanner may also be missed.

This is why PET results are always interpreted alongside other imaging, clinical history, and often biopsy. A negative PET scan does not rule out cancer. A positive one does not confirm it.

What Happens During a PET Scan and How Long Does It Take?

The tracer is injected into a vein, usually in the arm. You then wait. The wait allows the tracer to distribute through your body and be taken up by cells. For FDG-PET, that waiting period is typically around 60 minutes, though it can vary by protocol.

During the scan itself, you lie still on a table that moves through a ring-shaped scanner. The scan usually takes 20 to 40 minutes, depending on what area is being imaged and whether it is combined with CT. You may be asked to avoid talking, chewing, or moving during the scan because muscle activity also consumes glucose and can distort the image.

Before the scan, you will usually be asked to fast for several hours. This lowers blood glucose and improves the contrast between tissues that take up a lot of FDG and those that do not. You may also be asked to avoid strenuous exercise for a day before the scan for the same reason.

The radiation dose from a PET scan is higher than a single chest X-ray but comparable to or somewhat higher than a CT scan, depending on the tracer and protocol. The tracer decays relatively quickly, and the radiation leaves your body over hours to days. The risk from a single scan is generally considered low, but the benefit must justify the exposure — which is why PET is used when there is a specific clinical question to answer, not as a routine test.

Does a PET Scan Show Everything?

No. PET shows metabolic activity for whatever the tracer is designed to measure. It does not show blood vessels, bone structure, or soft tissue detail the way CT and MRI do. It does not measure organ function directly — it measures tracer uptake, which is a proxy for function.

It also does not distinguish between different causes of increased metabolism. A hot spot is a hot spot, whether it is cancer, infection, or inflammation. The reading physician uses location, pattern, and clinical context to make that call, but sometimes the answer requires a biopsy.

PET is a powerful tool precisely because it shows something other imaging cannot — the metabolic dimension of disease. But it is one tool. Its value comes from how it is used alongside everything else.